+ Follow PIOGLITAZONE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 783179
[Title] => Initial results show NASH improved with vitamin E
[Summary] => The use of vitamin E supplements by patients with nonalcoholic steatohepatitis was associated with a greater improvement in nonalcoholic fatty liver disease activity scores and cytologic ballooning, compared with the use of pioglitazone of placebo, results from a randomized controlled trial showed.
[DatePublished] => 2012-03-04 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 406636
[Title] => Pioglitazone cuts risk of progression to diabetes
[Summary] => People with impaired glucose tolerance were 81% less likely to develop type 2 diabetes over a three-year period if treated ...
[DatePublished] => 2008-10-12 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 75778
[Title] => The best medicines for diabetes
[Summary] =>
[DatePublished] => 2008-07-29 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
PIOGLITAZONE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 783179
[Title] => Initial results show NASH improved with vitamin E
[Summary] => The use of vitamin E supplements by patients with nonalcoholic steatohepatitis was associated with a greater improvement in nonalcoholic fatty liver disease activity scores and cytologic ballooning, compared with the use of pioglitazone of placebo, results from a randomized controlled trial showed.
[DatePublished] => 2012-03-04 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 406636
[Title] => Pioglitazone cuts risk of progression to diabetes
[Summary] => People with impaired glucose tolerance were 81% less likely to develop type 2 diabetes over a three-year period if treated ...
[DatePublished] => 2008-10-12 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 75778
[Title] => The best medicines for diabetes
[Summary] =>
[DatePublished] => 2008-07-29 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest